Biobank: Biobank for individuals with prostate cancer - Biobank for prostate cancer controls (Sweden): Difference between revisions
m (Update categories.) |
m (Update categories.) |
||
| Line 44: | Line 44: | ||
<span style="display:none">hasCancerType::C00-D48: All neoplasms</span> | <span style="display:none">hasCancerType::C00-D48: All neoplasms</span> | ||
<span style="display:none">hasCancerType::C00-C97: All cancer types</span> | <span style="display:none">hasCancerType::C00-C97: All cancer types</span> | ||
<span style="display:none">hasCancerType::C00-C14: Mouth/throat cancers</span> | |||
<span style="display:none">hasCancerType::C15-C26: Digestive system cancers</span> | |||
<span style="display:none">hasCancerType::C30-C39: Lung/chest cancers</span> | |||
<span style="display:none">hasCancerType::C40-C41: Bone cancers</span> | |||
<span style="display:none">hasCancerType::C43-C44: Skin cancers/melanoma</span> | |||
<span style="display:none">hasCancerType::C45-C49: Soft tissue cancer</span> | |||
<span style="display:none">hasCancerType::C50: Breast cancer</span> | |||
<span style="display:none">hasCancerType::C51-C58: Female genitalia cancers</span> | |||
<span style="display:none">hasCancerType::C64-C68: Urinary system cancers</span> | |||
<span style="display:none">hasCancerType::C69-C72: Eye and brain cancer</span> | |||
<span style="display:none">hasCancerType::C73-C75: Thyroid and other gland cancers</span> | |||
<span style="display:none">hasCancerType::C76-C80: Cancers of unknown or unspecified areas</span> | |||
<span style="display:none">hasCancerType::C81-C96: Cancers of the blood and immune system</span> | |||
<span style="display:none">hasCancerType::C97-C97: Cancers in multiple locations from the start</span> | |||
<span style="display:none">hasCancerType::D00-D09: Early-stage cancers not yet spread</span> | |||
<span style="display:none">hasCancerType::D10-D36: Benign tumour</span> | |||
<span style="display:none">hasCancerType::D37-D48: Growths of uncertain nature</span> | |||
<span style="display:none">hasCancerType::unknown</span> | |||
Revision as of 12:04, 6 December 2025
Go back to Sweden page
Type of database: survey, biobank.
Primary purpose: Store the sample collection and data information to study risk factors for prostate cancer.
Sponsor, manager or home institution: Lund University.
Type of information: cross-sectional. The participants had to submit a blood sample and answer questions regarding medication use, height, weight, alcohol consumption and smoking habit. Click here to learn more.
Source of information: Prostate cancer patients treated in an oncology clinic in southern Sweden were invited to participate in the study.
Data level: patient level.
Number of records: 1000. Click here to learn more.
Date range: 2007 onwards.
Cancer areas of interest: C60-C63: Male genitalia cancer. Click here to learn more.
Data access: not publicly available. Dataset information and contact to request data: Click here to learn access. Instructions to request data for restricted content: click here to learn more.
Contact information: Click here to learn more.